| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |